
News from hannibal.net
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top hannibal.net News

Hong Kong City · Hong KongHONG KONG, June 9, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, muscle-preserving weight loss drug candidate ASC47 will be presented at the 85th Scientific Sessions of American Diabetes Association (ADA) in Chicago, U.S. Details of the Poster Presentations Poster Number: 750-P Abs…See the Story
Ascletis Presents New Data on ASC30 and ASC47 at ADA 2025
95% Center coverage: 19 sources
3 Ways to Help Older Adults Combat Loneliness
80% Center coverage: 15 sources
Culver-Stockton's Delaney Straus qualifies for World Decathlon Championships
100% Center coverage: 1 sources
Economic Uncertainty Continues as Inventory Levels Rise Across Truck and Construction Equipment Markets
88% Center coverage: 16 sources